Exploring how to reduce CTC cells

Retrieved from AI-enabled searches

Circulating tumor cells (CTCs) - When do diet and exercise reduce them?

Wang X, Liu X, Jia Z, Zhang Y, Wang S, Zhang H. Evaluation of the Effects of Different Dietary Patterns on Breast Cancer: Monitoring Circulating Tumor Cells. Foods. 2021 Sep 19;10(9):2223. doi: 10.3390/foods10092223. PMID: 34574333; PMCID: PMC84 https://pmc.ncbi.nlm.nih.gov/articles/PMC8465684/

https://www.aicr.org/resources/media-library/10-cancer-prevention-recommendations/

AI-enabled searches

Yes, clinical evidence demonstrates that targeted diet and exercise interventions can reduce the presence, survival, and metastatic potential of circulating tumor cells (CTCs). While medical treatments remain primary, specific lifestyle adjustments can actively create a hostile environment for circulating cancer cells. [1, 2] 

------------------------------

## 🏃 Physical Exercise Mechanisms

Clinical studies, including pilot research from the [Dana-Farber Cancer Institute](https://www.dana-farber.org/newsroom/news-releases/2018/exercise-shown-to-reduce-numbers-of-circulating-tumor-cells-in-patients-with-colon-cancer), have shown that structured exercise directly lowers the number of CTCs in the bloodstream for certain patients. It works through several overlapping mechanisms: [1] 


* Fluid Shear Stress: Physical activity elevates heart rate and blood flow, increasing mechanical "fluid shear stress" inside the blood vessels. This physical turbulence mechanically breaks down and destroys fragile CTCs before they can attach to a secondary organ. [3, 4] 

* Immune System Mobilization: Exercise rapidly mobilizes cytotoxic immune cells, such as natural killer (NK) cells and T-cells, into the circulatory system. These active immune cells seek out and eliminate lone CTCs. [5] 

* Adhesion Reduction: Regular physical activity has been shown to decrease host adherence molecules like Intercellular Adhesion Molecule 1 (ICAM-1). Lower levels of these molecules make it much harder for CTCs to stick to blood vessel walls and exit into new tissues (extravasation). [6, 7] 


## Exercise Guidelines

Unifying oncology recommendations, such as the [American Cancer Society Guidelines](https://www.cancer.org/health-care-professionals/american-cancer-society-prevention-early-detection-guidelines.html), suggest targeting 150 to 300 minutes of moderate-intensity aerobic exercise (like brisk walking) or 75 to 150 minutes of vigorous-intensity exercise per week. Higher adherence to regular exercise directly correlates with a more significant reduction in CTC counts. [8, 9, 10] 

------------------------------

## 🥦 Dietary Interventions

Emerging laboratory models and human cohort studies suggest that dietary patterns directly affect how well CTCs survive or establish secondary micro-metastases. [11] 


* The Anti-Inflammatory / Mediterranean Approach: Diets high in whole grains, vegetables, fruits, and healthy fats (like olive oil and fish) reduce chronic systemic inflammation. Lower background inflammation suppresses the signaling pathways that tumors use to trigger cell shedding into blood vessels. [12, 13] 

* Insulin Regulation: Diets that minimize processed sugars, refined carbohydrates, and high-fat options prevent chronic spikes in blood sugar and fasting insulin levels. Elevated insulin and insulin-like growth factors (IGF-1) have been linked to increased survival and aggressive behavior in CTCs. [6, 11, 12] 

* Weight Management: Keeping a healthy body mass index (BMI) or undergoing structured weight loss reduces fat-tissue signaling molecules that would otherwise encourage CTC migration and colonizing capabilities. [6, 12] 


## Dietary Guidelines

Oncology lifestyle practices focus on building a heavily plant-based foundation: [14, 15] 


* Consume at least 2.5 cups of vegetables and fruits daily.

* Swap refined carbohydrates for nutrient-dense whole grains.

* Strictly limit the intake of highly processed foods, added refined sugars, and red meats. [15, 16] 


------------------------------

Disclaimer: This information is provided for general educational purposes only and does not constitute personalized medical advice. Always consult with an oncologist or a registered oncology dietitian before starting any new diet or exercise regimen during or after cancer therapy.

Are you looking into these lifestyle modifications for a specific type of cancer, or would you like to explore how metabolic factors like blood sugar affect tumor progression?


[1] [https://www.dana-farber.org](https://www.dana-farber.org/newsroom/news-releases/2018/exercise-shown-to-reduce-numbers-of-circulating-tumor-cells-in-patients-with-colon-cancer)

[2] [https://anticancer-living.com](https://anticancer-living.com/comprehensive-lifestyle-change/)

[3] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7071977/)

[4] [https://pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/28054593/)

[5] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9596782/)

[6] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7071977/)

[7] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6192582/)

[8] [https://www.sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S2095254625000146)

[9] [https://www.cancer.org](https://www.cancer.org/cancer/risk-prevention/diet-physical-activity/acs-guidelines-nutrition-physical-activity-cancer-prevention.html)

[10] [https://www.sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S2095254625000146)

[11] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8465684/)

[12] [https://www.nature.com](https://www.nature.com/articles/s41598-024-52065-9)

[13] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11893680/)

[14] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12735890/)

[15] [https://www.facingourrisk.org](https://www.facingourrisk.org/info/risk-management-and-treatment/nutrition-and-exercise)

[16] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8546934/)

Circulating tumor cells (CTCs) represent the critical physical link between the primary tumor and the formation of a metastasis. They are cancer cells that have detached from the primary mass, successfully broken through local boundaries, and entered the blood or lymphatic systems. [1, 2, 3] 

In the context of the tumor progression diagram provided in Chapter 18, CTCs occupy the crucial middle phase of the metastatic cascade—existing directly between intravasation (entering the vessel) and extravasation (exiting the vessel). [4, 5] 

## The Biological Journey of CTCs


* Intravasation: Tumor cells undergo an Epithelial-to-Mesenchymal Transition (EMT), allowing them to become mobile, lose adhesion, and squeeze through endothelial walls into the bloodstream. [2, 5] 

* Survival in Circulation: The bloodstream is a highly hostile environment. CTCs face immense physical fluid shear stress and constant attack from natural killer (NK) cells and macrophages. Because of these harsh conditions, fewer than 0.1% of CTCs survive in circulation. [6, 7, 8] 

* Traveling Patterns: CTCs migrate through vessels in two distinct formats:

* Single CTCs: Isolated individual cancer cells moving through vessels.

   * CTC Clusters (Micro-emboli): Groups of cancer cells aggregated together, sometimes cloaking themselves in non-tumor host cells like platelets or neutrophils. These clusters possess significantly higher metastatic potential and survival capability compared to single CTCs. [2, 9, 10] 

* Extravasation: Surviving CTCs eventually slow down, adhere to the endothelial wall of a distant organ, mimic leukocyte signaling pathways to pierce the vessel wall, and enter the new tissue to form a micro-metastasis. [11, 12] 


## Clinical Significance: "Liquid Biopsy"

Because CTCs circulate directly in peripheral blood, isolating them via a simple blood draw serves as a non-invasive liquid biopsy. Tracking CTC count and molecular profiling enables medical professionals to: [13] 


   1. Monitor Disease Progression: An increasing CTC count directly correlates with tumor progression, while a decreasing count reflects treatment containment or remission. [14] 

   2. Evaluate Heterogeneity: Analyzing individual CTCs reveals the diverse genetic mutations present across different regions of a patient's tumor without needing repeated, painful surgical tissue biopsies. [15, 16] 



[Metastatic circulating tumor cells (CTCs). Most tumor cells entering... | Download Scientific Diagram](https://www.researchgate.net/figure/Metastatic-circulating-tumor-cells-CTCs-Most-tumor-cells-entering-the-circulation-die_fig1_339618080), ResearchGate

[Circulating tumor cell - Wikipedia](https://en.wikipedia.org/wiki/Circulating_tumor_cell), Wikipedia

[Circulating tumor cells in the early detection of human cancers](https://www.ijbs.com/v18p3251.htm), International Journal of Biological Sciences

[Circulating tumor cells: from new biological insights to clinical practice | Signal Transduction and Targeted Therapy](https://www.nature.com/articles/s41392-024-01938-6), Nature

[Circulating Tumor Cells: The "Seeds" of Cancer Metastasis](https://www.accscience.com/journal/TD/special_issues/CTC), AccScience Publishing

[Amazon.com: Circulating Tumor Cells: Detection Methods, Health Impact and Emerging Clinical Challenges: 9781634844970: Ray, Paresh Chandra: Books](https://www.amazon.com/Circulating-Tumor-Cells-Detection-Challenges/dp/1634844971), Amazon.com

[Circulating tumor cells (CTC) detection: Clinical impact and future directions - ScienceDirect](https://www.sciencedirect.com/science/article/pii/S0304383506006860), ScienceDirect.com

[Frontiers | Circulating Tumor Cells: From Theory to Nanotechnology-Based Detection](https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00035/full), Frontiers

[CTC: Locating Tumor Cells – SQ Online](https://sqonline.ucsd.edu/2015/03/ctc-locating-tumor-cells/), SQ Online

[Advancements in Circulating Tumor Cell Research: Bridging Biology and Clinical Applications](https://www.mdpi.com/2072-6694/16/6/1213), MDPI

[Frontiers | Unveiling the dynamics of circulating tumor cells in colorectal cancer: from biology to clinical applications](https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2024.1498032/full), Frontiers

[Heterogeneity Landscape of Circulating Tumor Cells in Clinical Utility - Alam - 2025 - Advanced Therapeutics - Wiley Online Library](https://advanced.onlinelibrary.wiley.com/doi/10.1002/adtp.202400438), The Advanced Portfolio - Wiley


Would you like to explore how CTC clusters protect themselves from the immune system, or look closer at the technologies used to capture these rare cells during a liquid biopsy? [9, 15] 


[1] [https://www.nature.com](https://www.nature.com/articles/s41392-021-00817-8)

[2] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12580131/)

[3] [https://www.accscience.com](https://www.accscience.com/journal/TD/special_issues/CTC)

[4] [https://www.sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S0304383506006860)

[5] [https://www.sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S0304419X23000124)

[6] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9434215/)

[7] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11900898/)

[8] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7225923/)

[9] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9434215/)

[10] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10196185/)

[11] [https://www.nature.com](https://www.nature.com/articles/s41392-023-01725-9)

[12] [https://www.nature.com](https://www.nature.com/articles/srep43710)

[13] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7564158/)

[14] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC5697492/)

[15] [https://www.cell.com](https://www.cell.com/cancer-cell/fulltext/S1535-6108%2825%2900314-9)

[16] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9959336/)

The American Institute for Cancer Research (AICR) website provides evidence-based guidelines on how nutrition impacts oncological pathways.

When evaluating olive oil, the [AICR Official Website](https://www.aicr.org/) emphasizes looking at it through the lens of preventative dietary patterns rather than as a standalone clinical cure. [1, 2] 

------------------------------

## What AICR Science Says About Olive Oil## 1. Part of the Anti-Inflammatory Blueprint

The AICR explicitly highlights extra virgin olive oil in its [Mediterranean Diet Food Facts Guide](https://www.aicr.org/cancer-prevention/food-facts/mediterranean-diet/). Their analysis shows that dietary patterns rich in EVOO correlate with lower circulating blood markers of chronic inflammation. Because chronic inflammation can facilitate tumor cell migration and weaken endothelial tissues, reducing systemic inflammation makes it more difficult for breakaway cancer cells to find root elsewhere. [3, 4] 

## 2. The Power of Phenolic Compounds

In their research breakdowns, the AICR points out that the protective benefits observed in trials like PREDIMED are heavily tied to the phenolic compounds and tocopherols found specifically in unrefined extra virgin olive oil. These compounds serve as powerful antioxidants that help prevent oxidative damage, protecting cellular boundaries. [1, 5, 6] 

## 3. Caloric Substitution over Supplementation

A core piece of advice from the [AICR Lifestyle Recommendations](https://www.aicr.org/resources/media-library/10-cancer-prevention-recommendations/) is to avoid simply "adding" more fat to your diet. Instead, they advocate for swapping out less healthful lipids (such as saturated animal fats or highly refined industrial seed oils) and replacing them with high-quality olive oil. This keeps overall caloric intake balanced, which aligns with their mandate to maintain a healthy weight to reduce secondary risks. [1, 7, 8, 9] 

------------------------------

## How to Find AICR Tools Online

If you want to use the interactive features on their site to build an optimized nutritional layout, you can navigate directly to these hubs:


* To Assess Your Lifestyle: Use the [AICR Cancer Health Check Tool](https://www.instagram.com/p/DVD7rQWCSxg/) to map out your current eating habits and receive customized dietary adjustments. [10] 

* To Build a Healthier Routine: You can sign up for their free, interactive 10-week lifestyle blueprint located at the [AICR Healthy 10 Challenge Page](https://www.facebook.com/AmericanInstituteforCancerResearch/). [11] 


------------------------------

Would you like to examine how the AICR structures their "New American Plate" model to see exactly how they recommend balancing healthy fats alongside whole plant-based foods?


[1] [https://www.aicr.org](https://www.aicr.org/resources/blog/reducing-cancer-risk-with-mediterranean-diet-your-questions-answered/)

[2] [https://www.aicr.org](https://www.aicr.org/resources/blog/heart-healthy-mediterranean-diet-may-cut-breast-cancer-risk/)

[3] [https://www.aicr.org](https://www.aicr.org/resources/blog/can-an-anti-inflammatory-diet-reduce-cancer-risk/)

[4] [https://www.aicr.org](https://www.aicr.org/cancer-prevention/food-facts/mediterranean-diet/)

[5] [https://www.aboutoliveoil.org](https://www.aboutoliveoil.org/olive-oil-and-cancer)

[6] [https://www.youtube.com](https://www.youtube.com/watch?v=zsm6e1WsN8o)

[7] [https://www.aicr.org](https://www.aicr.org/resources/media-library/10-cancer-prevention-recommendations/)

[8] [https://www.youtube.com](https://www.youtube.com/watch?v=8dfIV6vGHvM&t=100)

[9] [https://www.aicr.org](https://www.aicr.org/cancer-prevention/food-facts/mediterranean-diet/)

[10] [https://www.instagram.com](https://www.instagram.com/p/DVD7rQWCSxg/)

[11] [https://www.facebook.com](https://www.facebook.com/AmericanCalifornia extra virgin olive oils (EVOOs) are globally recognized for health-conscious consumers due to strict local regulation and high-quality artisanal milling. The [California Olive Oil Council (COOC)](https://cooc.com/) enforces a maximum acidity standard of 0.5% (stricter than the international 0.8% benchmark), ensuring that certified oils maintain highly intact chemical structures. [1] 

When searching for California brands that provide maximum anti-metastatic punch (high oleocanthal and polyphenol levels to target CTC pathways), you should evaluate specific varietals, regions, and regional producers:

## High-Polyphenol California Cultivars to Look For


* Coratina: California-grown Coratina is a standout choice for cellular health. It yields exceptional, lab-tested polyphenol counts often ranging from 800 to nearly 1,000 mg/kg, characterized by an intense, coughing throat-sting. [2] 

* Mission & Picual: Cultivated extensively in California's Central Valley and coastal foothills, these varietals regularly yield a robust, highly stable phenolic punch. [3, 4] 

* Arbequina (A Note of Caution): Arbequina is California's most widely grown olive because it harvests easily. However, it naturally trends as a medium-to-low polyphenol oil (typically 150–350 mg/kg). Avoid plain Arbequina blends if your goal is an aggressive, therapeutic-grade antioxidant profile. [5, 6] 


------------------------------

## Key California Producers Producing "High-Phenolic" Batches

The following boutique or specialty California farms consistently produce early-harvest, lab-certified high-polyphenol lines: [7] 

[McEvoy Ranch](https://www.google.com/search?kgmid=/g/1tf1p1n4&q=McEvoy+Ranch)


* The Profile: Known for estate-grown organic blends utilizing traditional Tuscan varieties (Frantoio, Leccino, Moraiolo).

* What to look for: Their "Robust" or "Early Harvest" releases. They openly document how their harvest timing optimizes compound integrity. [4, 8, 9] 


Wild Groves


* The Profile: This mill specializes in limited-run, single-varietal presses.

* What to look for: Their Coratina Extra Virgin Olive Oil regularly tops out at near-maximum legal yields, testing as high as 999 mg/kg total polyphenols via HPLC testing.


[Apollo Olive Oil](https://www.google.com/search?kgmid=/g/12605_fgn&q=Apollo+Olive+Oil)


* The Profile: They employ specialized vacuum-milling machines specifically to protect fragile polyphenols from thermal oxidation during extraction.

* What to look for: Their "Mistral" or "Gold Medal" Organic lines. They have a history of working directly with international food science researchers studying how early extraction influences metabolic and chronic inflammatory pathways. [10, 11] 


[Cobram Estate](https://www.google.com/search?kgmid=/g/11c1wx33fh&q=Cobram+Estate)


* The Profile: A massive, highly transparent commercial producer that brings clinical consistency to retail store shelves.

* What to look for: Skip their standard everyday oil and specifically purchase the Cobram Estate Ultra Premium "Robust" or single-varietal lines. They explicitly stamp clear harvest dates right on the labels. [6] 


------------------------------

## Summary Checklist for California Oils

If you are standing in a store aisle looking at a bottle of California olive oil, perform this quick physical evaluation:


* Look for the COOC Seal: Ensures it is authentic, pure 100% California EVOO rather than a cheap, pre-cut oil imported from overseas. [1, 12] 

* Flip to the back label: Avoid anything that says "Smooth," "Mild," or "Buttery." You want terms like "Robust," "Early Harvest," "First Press," or "Green Fruit." [4, 8, 13] 

* Check the container: Ensure the oil is housed in an opaque tin, dark amber glass, or ultraviolet-protected glass. Clear glass allows light to instantly break down the exact oleocanthal rings needed to combat tumor migration. [8, 14] 


Disclaimer: This information is for educational purposes regarding dietary compound profiles and does not constitute medical advice or a personalized treatment plan for oncological care.


[1] [https://bhooc.com](https://bhooc.com/blogs/articles/california-olive-oil-vs-imported-oils-key-differences)

[2] [https://www.instagram.com](https://www.instagram.com/reel/DUyo8FfDpHi/?hl=en)

[3] [https://www.mcevoyranch.com](https://www.mcevoyranch.com/blogs/learn/discover-high-polyphenol-extra-virgin-olive-oils)

[4] [https://www.mcevoyranch.com](https://www.mcevoyranch.com/blogs/learn/what-is-a-good-polyphenol-count-in-organic-extra-virgin-olive-oil)

[5] [https://www.myolivea.com](https://www.myolivea.com/blogs/news/california-olive-ranch-olive-oil)

[6] [https://www.facebook.com](https://www.facebook.com/groups/694281934016818/posts/9054993867945541/)

[7] [https://www.facebook.com](https://www.facebook.com/groups/694281934016818/posts/9054993867945541/)

[8] [https://www.mcevoyranch.com](https://www.mcevoyranch.com/blogs/learn/discover-high-polyphenol-extra-virgin-olive-oils)

[9] [https://oliveoilprofessor.com](https://oliveoilprofessor.com/blog/9-high-phenolic-olive-oils-for-health)

[10] [https://bhooc.com](https://bhooc.com/blogs/articles/11-best-high-polyphenol-olive-oils)

[11] [https://www.apollooliveoil.com](https://www.apollooliveoil.com/organic-extra-virgin/index.php/category/health/)

[12] [https://www.lifeextension.com](https://www.lifeextension.com/magazine/2016/9/is-your-olive-oil-counterfeit)

[13] [https://www.youtube.com](https://www.youtube.com/shorts/IWkqexVZ978)

[14] [To maximize the intake of anti-metastatic compounds like oleocanthal and hydroxytyrosol while minimizing the potentially compounding structural effects of pure refined oleic acid, you must focus closely on the olive cultivar (variety), harvest timing, and milling process. [1, 2] 

The levels of total polyphenols (measured in mg/kg) dictate an oil’s biological potency against Circulating Tumor Cells (CTCs). [1, 2] 

------------------------------

## Comparison of Olive Oil Profiles


| Attribute [1, 3, 4, 5, 6, 7, 8, 9, 10] | Ultra-High Phenolic EVOO (Target for Therapeutic Action) | Standard Extra Virgin Olive Oil (Daily Dietary Fat) | Refined / "Light" Olive Oil (Cooking Grade) |

|---|---|---|---|

| Total Polyphenols | 800 to 3,000+ mg/kg | 150 to 400 mg/kg | Virtually 0 mg/kg |

| Primary Cultivars | Coratina, Koroneiki, Picual | Arbequina, Mission, Leccino | Multi-national blends |

| Harvest Window | Early Harvest (Oct / Green fruit) | Mid-to-Late Harvest (Nov–Jan) | Over-ripe / Fallen fruit |

| Sensory Indicator | Intense peppery throat burn | Mild fruitiness, smooth finish | Neutral, no throat sting |

| Effect on CTCs | High selective cytotoxicity | Minimal impact on viability | Neutral / Fuel source only |


------------------------------

## Core Factors Driving Anti-Metastatic Potency## 1. Olive Cultivar (The Variety)

Certain olive trees possess stress-response genes that naturally manufacture much higher quantities of complex secoiridoids (like oleocanthal). [4] 


* Koroneiki (Greece) & Coratina (Italy): These produce smaller fruits. Because polyphenols heavily concentrate within the skin, their higher skin-to-flesh ratio dramatically boosts the final antioxidant yield per kilogram.

* Picual (Spain): Noted for immense chemical stability and high initial fractions of defensive polyphenols. [4] 


## 2. Harvest Timing (The "Early" Window)

To secure maximum oleocanthal, olives must be harvested when they are completely green and unripened (often called Early Harvest or First Harvest oils). [1, 11] 


* The Trade-off: Green olives yield far less oil volume than ripe, dark olives and require specialized mechanical harvesting. However, as the fruit ripens on the tree, its polyphenol count plummets while the basic lipid content (oleic acid) rises. [1, 11] 


## 3. Milling Temperature and Processing

Phenolic molecules are highly water-soluble and hypersensitive to heat or oxygen exposure.


* High-potency oils require cold-pressing (strictly keeping temperatures below 27°C / 80.6°F) under a nitrogen vacuum protectant buffer.

* If a thermal or chemical refining process is utilized to make standard cooking oil, the volatile ring structures of oleocanthal are entirely sheared away, leaving behind pure oleic acid without the protective antioxidant armor. [2, 3, 12] 


## Direct Shopping Checklist

If you are looking for oils with documented biological activity, you cannot rely on a standard grocery store label. Look for brands that clearly list: [13] 


   1. Harvest Date: Ensure it states the exact month and year of the latest harvest cycle (do not confuse this with an expiration date).

   2. Specific Monocultivar: It should identify a specific bean/fruit type, such as 100% Coratina, rather than "Mediterranean Blend".

   3. Certificate of Analysis (CoA): Reputable high-phenolic producers provide lab-verified assays explicitly stating the exact oleocanthal or total polyphenol count in mg/kg. [1, 2, 5] 


------------------------------

If you have a specific brand or bottle you are considering, let me know its harvest notes or country of origin, and I can help you evaluate its potential polyphenol profile. [5] 


[1] [https://oliveoilprofessor.com](https://oliveoilprofessor.com/blog/9-high-phenolic-olive-oils-for-health)

[2] [https://bhooc.com](https://bhooc.com/blogs/articles/oleocanthal-olive-oil-anti-cancer-properties)

[3] [https://bhooc.com](https://bhooc.com/blogs/articles/antioxidant-levels-in-olive-oils-a-comparison)

[4] [https://www.best-olive-oil-ranked.com](https://www.best-olive-oil-ranked.com/research/cultivars)

[5] [https://www.youtube.com](https://www.youtube.com/watch?v=riFXWwL6zdM)

[6] [https://researchoutreach.org](https://researchoutreach.org/articles/diet-cancer-investigating-mechanisms-polyphenolic-compounds-extra-virgin-olive-oil/)

[7] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9146374/)

[8] [https://pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6693737/)

[9] [https://www.hunter.cuny.edu](https://www.hunter.cuny.edu/news/hunter-study-shows-that-certain-olive-oils-kill-cancer-cells/)

[10] [https://www.sciencedaily.com](https://www.sciencedaily.com/releases/2026/06/260601025349.htm)

[11] [https://www.youtube.com](https://www.youtube.com/watch?v=PM8HBeMktVc&vl=en&t=52)

[12] [https://news.harvard.edu](https://news.harvard.edu/gazette/story/2024/03/surprising-link-to-an-everyday-food-in-cancer-findings/)

[13] [https://www.youtWhile the textbook page provided explains the general mechanics of metastasis—the spread of cancer cells from a primary tumor to distant sites—it does not mention olive oil. However, scientific research into the "Mediterranean Diet" highlights several ways components of extra-virgin olive oil (EVOO) may influence circulating tumor cells (CTCs) and the metastatic process: 

1. Inhibition of the "Invasion Cascade" As shown in the "Tumor Progression" diagram (Figure 18-1), cells must undergo intravasation (entering the blood or lymph) to become CTCs. 


• Oleocanthal, a phenolic compound in EVOO, has been shown to inhibit the epithelial-mesenchymal transition (EMT). By keeping cells in a more "anchored" state, it reduces their ability to break away and enter circulation. 

• Polyphenols like hydroxytyrosol can inhibit enzymes (MMPs) that cancer cells use to degrade the surrounding tissue, physically blocking the first step of the journey. 


2. Selective Cytotoxicity (Killing CTCs) Once in the bloodstream, CTCs are vulnerable. Research indicates that oleocanthal can induce Lysosomal Membrane Permeabilization (LMP). 


• Because cancer cells (including CTCs) often have larger, more fragile lysosomes, oleocanthal can cause these "waste centers" to rupture, releasing digestive enzymes that kill the cancer cell while leaving healthy cells unharmed. 


3. Suppression of Survival Pathways CTCs must survive the "harsh" environment of the bloodstream to form a new colony. 


• Olive oil components can block survival signaling pathways such as c-MET and STAT3, which are often overactive in CTCs and necessary for them to survive and eventually "seed" in a new organ. 


4. Nuance: The Role of Oleic Acid Recent studies (2024–2026) have added complexity, suggesting that while the phenols in olive oil are highly anti-metastatic, oleic acid (the primary fat in olive oil) may sometimes act as a protective "shield" for melanoma cells in the lymph nodes. This highlights the importance of using high-phenolic, extra-virgin oils rather than refined versions. 

Would you like to see a comparison of which specific types of olive oil (e.g., harvest time or variety) contain the highest levels of these anti-metastatic compounds? 


AI responses may include mistakes.


ube.com](https://www.youtube.com/shorts/IWkqexVZ978)

https://nclnet.org](https://nclnet.org/evoo_testing/)

InstituteforCancerResearch/)


Invasion and Metasthesis


from "The Molecular Basis of Cancer"
This excerpt from the book Invasion and Metastasis (from "The Molecular Basis of Cancer") highlights why the spread of cancer is the most life-threatening attribute of the disease. While tumors confined to their original tissue have near 100% cure rates, spreading or metastasis often renders the cancer incurable.

18

Swarnali Acharyya, Lynn Matrisian, Danny R. Welch, and Joan Massagué

Invasion and Metastasis

In the written history of medicine, neoplasnis have been diagnosed for nearly 4000 years. Almost from the begin-ning, medical practitioners recognized that the most life-threatening attribute of neoplastic cells is the ability to disseminate and colonize distant tissues. When tumors are diagnosed and have not spread beyond the tissue of origin. cure rates for most cancers approach 100%. However, when tumor cells have established colonies elsewhere, cancer is often incurable.

The process of converting a normal cell into a life-threatening metastatic cancer cell is referred to as tumor progression (Figure 18-1). As discussed in previ-ous chapters, medicine has evolved toward a recognition that neoplasia is a cellular disease, and further advanced to understand the molecular underpinnings of the early stages of progression resulting in cancer development. It is now recognized that metastases represent a subset of cells that have left the primary tumor, which are behavior-ally distinct from the cells remaining at the site of tumor origin, and the molecular mechanisms underlying the phe notypic differences that characterize a metastatic cell are being elucidated.

Generation of a Metastatic Cell

Metastasis is defined as the dissemination of neoplas-tic cells to discontiguous nearby or distant secondary sites where they proliferate to form a mass. But how did tumor cells acquire the ability to metastasize? The answer to this question requires examination of the mechanisms underly-ing how tumors arose and progressed toward increasingly aggressive behavior.

By the time a neoplasm is diagnosed, it comprises ar least 10 cells. Yet, even cursory examination of a tumor his-tologically reveals that the cells are pleiomorphic. Further more, if one isolates single cell clones from a tumor, they vary dramatically in terms of biological behavior.

Tumor heterogeneity exists for virtually every phe-notype measured. There are three types of heterogeneity within a tumor: positional, temporal, and genetic. Positional heterogeneity is determined by the accessibility of a cell to external stimuli (e.g., oxygen [O2] levels). For example, radiation sensitivity is proportional to oxygenation; there-fore, two identical cells would exhibit differences in radio-response depending on distance from a capillary. Temporal heterogeneity is relevant with regard to changes in cells due to cyclical signals. Cells in the Go/G₁ phase of the cell cycle would be less sensitive than cells in the S phase to drugs tar-geting DNA replication. Genetic heterogeneity is the result of inherent properties of tumor cells themselves. Isolation of single-cell clones confirms that there are inherent differ-ences between subpopulations comprising a single tumor mass.

The heterogeneity of tumors raises an important ques-tion regarding tumor origin: Are tumors of unicellular or multicellular origin? Tumors express maternal or paternal isoenzymes, but rarely both, strongly suggesting that they arose from a single cell. Analysis of karyotypes reveals that virtually ali cells within a tumor share a common abnormal chromosomal change (e.g., all CML, cells have t(9:22]). Additional karyotypic abnormalities may be superimposed on the shared ones. If tumors are monocional, how, then, does heterogeneity arise?

Normal Benign

Malignant

Micro-metastatic

Metastatic

Initiation

Promation

Growth Co

Angiogenesis

Intravasation Transport

Conversion

Invasion

Arrest

Colonization Sustained Extravasation growth

METASTASIS

TUMOR PROGRESSION

FIGURE 18-1 TUMOR PROGRESSION

269


Colonoscopy preparation


 

 

 

 

 

 

 

 

 

CHOICES:DC Metro Colonoscopy Preparation Instructions

Please read and follow the instructions for the specific prep your provider has prescribed for you. Please visit your patient portal if you are unsure which prep you have been prescribed.

  1. Clear Liquid Diet

    1.         Clenpiq Clear Liquid Prep for Colonoscopy  
    2.         Ez2go Clear Liquid Prep for Colonoscopy
    3.         Pegprep Clear Liquid for Colonoscopy  
    4.         Plenvu Clear Liquid Prep Kit for Colonoscopy  
    5.         Suprep Clear Liquid Prep for Colonoscopy  link
    6.         Sutab Clear Liquid Prep for Colonoscopy  
    7.         Suflave Clear Liquid Prep for Colonoscopy  
     
  2. Low Residue Diet

    1.         Clenpiq Low Residue Prep for Colonoscopy  
    2.         Ez2go Low Residue Prep for Colonoscopy
    3.         Pegprep Low Residue Prep for Colonoscopy  
    4.         Plenvu Low Residue Prep Instructions  
    5.         Suflave Low Residue Prep for Colonoscopy
    6.         Suprep Low Residue Prep for Colonoscopy
    7.         Sutab Low Residue Prep for Colonoscopy  

    Source: https://www.capitaldigestivecare.com/appointment-information/appointment-forms-procedure-instructions/ (2024-11-06)

Anxiety

fear of surgery — tomophobia
"some patients [] are afraid they won’t wake up from surgery

-- Anesthesiologist in a 2017 interview on minimizing pre-surgery.





Greek: tomos, cut






Which level of detail is more effective?

(A)
FILMS COMPARED:
Prior Images available and compared.

FINDINGS:
The breasts have scattered fibroglandular tissue. The background parenchymal enhancement is mild.
No interval development of suspicious focus of enhancement or suspiciously enhancing mass in either breast.
No axillary adenopathy.

(B)
Contrast Bilateral
IMPRESSION: Bi-RÄDS 2- BENIGN
1. Bilateral 3 mm well-circumscribed enhancing nodules which are unchanged and are benign.
2. No suspicious mass or abnormal enhancement seen in either breast.

FULL RESULT: Mild diffuse background enhancement is present bilaterally.
The chest wall, axillary regions, internal mammary regions and limited visualization of the upper abdomen and chest wall are unremarkable.
RIGHT BREAST FINDINGS: A 3 well—circumscribed heterogeneously enhancing nodule in the right anterior breast at 7:00 (#6/81) is entirely unchanged from 9/4/13 and earlier studies. This is bright on the T2-weighted sequence (#4/82) and is benign. No suspicious mass or enhancement is seen in the right breast.
LEFT BREAST FINDINGS: A 3 mm well-circumscribed nodule in the left anterior breast directly behind the nipple (#6/74) today shows heterogeneous enhancement on the subtraction color images but is unchanged in size from 9/4/13 and 8/12/10 (#500/25) . This is bright on the T2—weighted sequence and is a benign lesion. No suspicious mass or enhancement is seen in the left breast.




Practice guidelines for MRI surveillance for long-term follow-up

Ask customer service to find you the practice guideline!

(1) notesnet.carefirst.com Open Doc  < provider.carefirst.com search on query=mri+breast*&amp
MRI of the breast is considered medically necessary for the following indications for screening for breast cancer in the following high risk patients:
  • with a known BRCA1 or BRCA2 mutation; or
  • a high-risk of BRCA1 or BRCA2 mutation, due to the known presence of the mutation in first or second-degree relatives (male or female); * or
  • who have Li-Fraumeni syndrome or Cowden syndrome or Bannayan-Riley-Ruvalcaba syndrome or who have a first-degree relative with one of these syndromes, or
  • at high risk (20% or greater lifetime risk) of developing breast cancer as identified by model ** that are largely defined by family history, or
  • in conjunction with mammography for women with a lifetime risk >20% based on a history of lobular carcinoma in situ (LCIS) or atypical ductal hyperplasia (ADH)/atypical lobular hyperplasia (ALH) or
  • who received radiation therapy to the chest between the ages of 10 and 30 years of age.
Does not include men in Tennessee BCBS?
Women with history of radiation to the chest between ages 10 and 30. (If history of Hodgkin’s Disease, breast screening should start 8 to 10 years post-therapy, or at age 40,...

https://www.anthem.com/medicalpolicies/policies/mp_pw_a053263.htm
http://www.aetna.com/cpb/medical/data/100_199/0105.html

(1) MRI of the breast for routine screening purposes, is considered experimental / investigational, as it does not meet TEC criteria # 2 - 5.
MRI of the breast for all other conditions is considered not medically necessary.
* NOTEFirst-degree relatives includes the patient's parents, full siblings, and children. A second-degree relative includes the individual's grandparents, grandchildren, aunts, uncles, nephews, nieces, and half siblings.
** Examples of models used in estimating risk and that utilize family history include the Claus, Tyrer-Cusick and BRCAPRO models (see References, Claus, et al; Parmigiani, et al; Tyrer, et al).